Osborne Clarke advised Taylor Wimpey on the deal. Taylor Wimpey has won planning approval for its pioneering heating network at its Chilton Woods development. Taylor Wimpey’s...
Taylor Wimpey’s Approval for its Chilton Woods Development
Vodafone’s Sale of The Connection Business Campus in Newbury
Osborne Clarke advised Vodafone on the deal. Addleshaw Goddard acted as legal advisers of the purchaser. Addleshaw Goddard acted as legal advisers of the purchaser, while...
Bristol City Council’s Joint Venture With Ameresco
Burges Salmon has advised Bristol City Council on the deal. Osborne Clarke has advised Ameresco Ltd. Bristol City Council’s City Leap project agreed for a twenty-year...
Pulpex’s Financing Round
Osborne Clarke represented Pulpex, while Carey represented CMPC Ventures in the transaction. Pulpex executed its financing round, led by CMPC Ventures, together with other investors. Pulpex is a...
LACE Partners’ £10.2 Million Investment From Mobeus
Freeths advised LACE Partners on the deal. Osborne Clarke advised Mobeus Equity Partners LLP. LACE Partners, a fast-growing HR transformation consultancy, was granted a £10.2m investment...
Allcargo Logistics’ Acquisition of Shares in Fair Trade GmbH
Osborne Clarke advised global logistics provider Allcargo Logistics. Allcargo Logistics acquired a 75 percent stake in German logistics provider Fair Trade GmbH. The acquisition took place...
Telemedicine Technologies’ Acquisition of CTMA, CT-Scout and Totem4me
Vaughan Avocats advised Telemedicine Technologies. The shareholders of CTMA were advised by Yooner Avocats. CTMA was advised by Osborne Clarke. Telemedicine Technologies has acquired the start-up...
Foresight Group’s Scotland Fund Raising
Osborne Clarke advised Foresight Group on the deal. Foresight Group, a leading listed regional private equity and infrastructure investment manager, has announced the launch of a...
Lucid Group’s Acquisition of Synetic Life Sciences
Osborne Clarke has advised Lucid Group on the deal. Lucid Group acquired leading consulting firm, Synetic Life Sciences. The acquisition will further accelerate Lucid Group’s mission...
Bloomsbury Genetic Therapies Limited’s £5 Million Seed Financing
Osborne Clarke advised UCL Technology Fund on the investment. Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from...
PayProp’s Growth Capital Investment
Osborne Clarke has advised PayProp on the deal. PayProp, a leading processor of rental payments for the property management industry, was granted a significant investment by...
Oxbotica’s US$140 Million Series C Funding Round
Osborne Clarke advised BGF on the deal. BGF invested in Oxbotica’s US$140m Series C funding round. The funding will be used to drive Oxbotica’s global expansion...